Certara Inc (CERT)

$9.51 -0.01 (-0.11%)
Market Cap 1.52B
Revenue (ttm) 385.15M
Net Income (ttm) -12.05M
EPS (ttm) N/A
PE Ratio 27.41
Forward PE 26.89
Profit Margin -3.13%
Debt to Equity Ratio 0.28
Volume 1,884,100
Avg Vol 2,411,590
Day's Range N/A - N/A
Shares Out 159.27M
Stochastic %K 56%
Beta 1.46
Analysts Strong Sell
Price Target $12.79

Company Profile

Certara, Inc., together with its subsidiaries, provides technology-enabled services and software products for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers solutions for model-informed drug development, as well as biosimulation solutions to predict pharmacokinetics and pharmacodynamics; Simcyp simulator, a mechanistic biosimulation platform for physiologically based pharmacokinetic simulation; Simcyp Discovery for scienti...

Industry: Health Information Services
Sector: Healthcare
Phone: 415 237 8272
Address:
4 Radnor Corporate Center, Suite 350, Radnor, United States
stockingu
stockingu Jan. 14 at 3:01 PM
$PRSU, $CERT , $CRWV , $CRCL
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 13 at 8:24 PM
$CERT RSI: 51.55, MACD: 0.0287 Vol: 0.30, MA20: 9.05, MA50: 9.17 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
UgoGreg
UgoGreg Jan. 10 at 3:41 PM
$CERT https://youtu.be/ygBN8MilTyc
0 · Reply
ItoLemmaI
ItoLemmaI Dec. 26 at 3:51 PM
$CERT Expectations are recalibrating toward pragmatic delivery instead of lofty projections. Efficiency initiatives must translate into measurable productivity. Overextension would degrade optionality during downturns. The trajectory strengthens as results compound visibly.
0 · Reply
JarvisFlow
JarvisFlow Dec. 18 at 5:42 PM
Morgan Stanley has updated their rating for Certara ( $CERT ) to Equal-Weight with a price target of 12.
0 · Reply
JarvisFlow
JarvisFlow Dec. 15 at 8:57 PM
Barclays has updated their rating for Certara ( $CERT ) to Overweight with a price target of 13.
0 · Reply
Estimize
Estimize Dec. 15 at 12:09 PM
Wall St is expecting 0.11 EPS for $CERT Q4 [Reporting 02/26 AMC] http://www.estimize.com/intro/cert?chart=historical&metric_name=eps&utm_co
0 · Reply
JarvisFlow
JarvisFlow Dec. 12 at 12:43 PM
Stephens & Co. updates rating for Certara ( $CERT ) to Overweight, target set at 15 → 12.
0 · Reply
BigDaddyCapital
BigDaddyCapital Dec. 11 at 8:33 PM
$CDXS I’m not sure which company is a bigger bioturd… $CDXS OR $CERT. Both are awful investments.
1 · Reply
BigDaddyCapital
BigDaddyCapital Dec. 11 at 2:53 PM
$CERT worst company in biotech…
0 · Reply
Latest News on CERT
Tax-related selling could set up these 11 stocks for big gains early in 2026

Dec 31, 2025, 10:57 AM EST - 16 days ago

Tax-related selling could set up these 11 stocks for big gains early in 2026

CNH CNS COTY FRSH GOGO JJSF KNTK

Certara Appoints Jon Resnick as Chief Executive Officer

Dec 11, 2025, 6:00 AM EST - 5 weeks ago

Certara Appoints Jon Resnick as Chief Executive Officer

Cerrado Gold Inc. (CERT:CA) Q3 2025 Earnings Call Transcript

Dec 1, 2025, 5:13 PM EST - 6 weeks ago

Cerrado Gold Inc. (CERT:CA) Q3 2025 Earnings Call Transcript

Touchstone Small Company Fund Q3 2025 Performance Review

Nov 27, 2025, 9:30 AM EST - 7 weeks ago

Touchstone Small Company Fund Q3 2025 Performance Review

APLE CIEN EME GPOR HAE KLIC MMS

Certara, Inc. (CERT) Presents at Stephens Annual Investment Conference 2025 Transcript

Nov 18, 2025, 4:48 PM EST - 2 months ago

Certara, Inc. (CERT) Presents at Stephens Annual Investment Conference 2025 Transcript

Certara, Inc. (CERT) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 18, 2025, 7:38 AM EST - 2 months ago

Certara, Inc. (CERT) Presents at Jefferies London Healthcare Conference 2025 Transcript

Certara, Inc. (CERT) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 8:56 PM EST - 2 months ago

Certara, Inc. (CERT) Q3 2025 Earnings Call Transcript

Certara Reports Third Quarter 2025 Financial Results

Nov 6, 2025, 4:15 PM EST - 2 months ago

Certara Reports Third Quarter 2025 Financial Results

Certara Automates Scientific Workflows with Phoenix® Cloud

Nov 4, 2025, 8:00 AM EST - 2 months ago

Certara Automates Scientific Workflows with Phoenix® Cloud

Certara to Participate in Upcoming Investor Conferences

Oct 31, 2025, 8:00 AM EDT - 2 months ago

Certara to Participate in Upcoming Investor Conferences

Certara Expands Biosimulation Market with AI-Driven QSP Platform

Oct 30, 2025, 4:15 PM EDT - 2 months ago

Certara Expands Biosimulation Market with AI-Driven QSP Platform

Certara Scientists are Among the Topmost Cited Biopharma Researchers

Oct 20, 2025, 8:00 AM EDT - 3 months ago

Certara Scientists are Among the Topmost Cited Biopharma Researchers

Why Investors Should Consider Certara Again

Oct 15, 2025, 5:55 PM EDT - 3 months ago

Why Investors Should Consider Certara Again

Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025

Oct 10, 2025, 8:00 AM EDT - 3 months ago

Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025

Final Trade: CERT, GDX, IWM, MPC

Sep 23, 2025, 6:34 PM EDT - 4 months ago

Final Trade: CERT, GDX, IWM, MPC

GDX IWM MPC

Certara, Inc. (CERT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 10, 2025, 2:40 PM EDT - 4 months ago

Certara, Inc. (CERT) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Certara, Inc. (CERT) Presents At Baird Global Healthcare Conference 2025 (Transcript)

Sep 9, 2025, 12:21 PM EDT - 4 months ago

Certara, Inc. (CERT) Presents At Baird Global Healthcare Conference 2025 (Transcript)

Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster

Sep 4, 2025, 8:00 AM EDT - 4 months ago

Certara Launches Pinnacle 21® Enterprise Plus to Deliver Regulatory Submissions Faster

Cerrado Gold Inc. (CRDOF) Q2 2025 Earnings Call Transcript

Aug 25, 2025, 1:32 PM EDT - 5 months ago

Cerrado Gold Inc. (CRDOF) Q2 2025 Earnings Call Transcript

Certara, Inc. (CERT) Q2 2025 Earnings Call Transcript

Aug 6, 2025, 10:24 PM EDT - 5 months ago

Certara, Inc. (CERT) Q2 2025 Earnings Call Transcript

Certara Reports Second Quarter 2025 Financial Results

Aug 6, 2025, 4:15 PM EDT - 5 months ago

Certara Reports Second Quarter 2025 Financial Results

Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling

Aug 4, 2025, 2:00 AM EDT - 5 months ago

Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling

Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform

Jul 31, 2025, 4:15 PM EDT - 6 months ago

Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform

Certara: Ideally Positioned To Benefit From IT Innovation In Life Sciences

Jul 11, 2025, 3:09 AM EDT - 6 months ago

Certara: Ideally Positioned To Benefit From IT Innovation In Life Sciences

Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025

Jul 9, 2025, 4:15 PM EDT - 6 months ago

Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025

Certara Announces Expansion of Clinical Technology Collaboration with Merck

Jul 8, 2025, 8:00 AM EDT - 6 months ago

Certara Announces Expansion of Clinical Technology Collaboration with Merck

Certara, Inc. (CERT) Q1 2025 Earnings Call Transcript

May 5, 2025, 7:22 PM EDT - 9 months ago

Certara, Inc. (CERT) Q1 2025 Earnings Call Transcript

Certara Reports First Quarter 2025 Financial Results

May 5, 2025, 4:15 PM EDT - 9 months ago

Certara Reports First Quarter 2025 Financial Results

Certara Unveils $100 Million Buyback Plan In Better-Than-Expected Preliminary Earnings Report

Apr 14, 2025, 2:08 PM EDT - 9 months ago

Certara Unveils $100 Million Buyback Plan In Better-Than-Expected Preliminary Earnings Report

Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing

Apr 14, 2025, 8:15 AM EDT - 9 months ago

Certara Launches Non-Animal Navigator™ Solution to Help Drug Developers Reduce Reliance on Animal Testing

Buy Certara After The FDA Announcement

Apr 11, 2025, 1:15 PM EDT - 10 months ago

Buy Certara After The FDA Announcement

What's Going On With Charles River, Certara, Simulations Plus Stocks On Friday?

Apr 11, 2025, 10:44 AM EDT - 10 months ago

What's Going On With Charles River, Certara, Simulations Plus Stocks On Friday?

CRL SLP

Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities

Apr 1, 2025, 8:00 AM EDT - 10 months ago

Certara Expands the Simcyp™ Simulator Platform Advancing Biopharmaceutics, Drug-Drug Interaction & Biologic Capabilities

Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions

Mar 5, 2025, 4:15 PM EST - 11 months ago

Certara Appoints Dr. Adrian McKemey as President of Drug Development Solutions

Certara, Inc. (CERT) Q4 2024 Earnings Call Transcript

Feb 26, 2025, 8:03 PM EST - 11 months ago

Certara, Inc. (CERT) Q4 2024 Earnings Call Transcript

Certara Reports Fourth Quarter 2024 Financial Results

Feb 26, 2025, 4:15 PM EST - 11 months ago

Certara Reports Fourth Quarter 2024 Financial Results

Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences

Jan 29, 2025, 4:15 PM EST - 1 year ago

Certara to Report Fourth Quarter and Full Year 2024 Financial Results on February 26th, 2025 and Participate in Upcoming Investor Conferences

Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results

Jan 15, 2025, 7:55 AM EST - 1 year ago

Certara Reports Preliminary Fourth Quarter and Full Year 2024 Financial Results

Final Trade: CERT, XLE, DAL, OKTA

Jan 10, 2025, 7:14 PM EST - 1 year ago

Final Trade: CERT, XLE, DAL, OKTA

OKTA XLE DAL

Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Jan 2, 2025, 4:15 PM EST - 1 year ago

Certara to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Certara Showcases 2024 Research Wins With Over 100 Papers Published

Dec 2, 2024, 4:15 PM EST - 1 year ago

Certara Showcases 2024 Research Wins With Over 100 Papers Published

Certara, Inc. (CERT) Q3 2024 Earnings Conference Call Transcript

Nov 6, 2024, 9:09 PM EST - 1 year ago

Certara, Inc. (CERT) Q3 2024 Earnings Conference Call Transcript

Certara Reports Third Quarter 2024 Financial Results

Nov 6, 2024, 4:15 PM EST - 1 year ago

Certara Reports Third Quarter 2024 Financial Results

Certara to Participate in the Stephens Annual Investment Conference

Oct 28, 2024, 4:15 PM EDT - 1 year ago

Certara to Participate in the Stephens Annual Investment Conference

Certara Appoints John Reynders as New Independent Board Member

Oct 16, 2024, 4:15 PM EDT - 1 year ago

Certara Appoints John Reynders as New Independent Board Member

Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024

Oct 9, 2024, 4:15 PM EDT - 1 year ago

Certara to Report Third Quarter 2024 Financial Results on November 6th, 2024

Certara Completes Acquisition of Chemaxon

Oct 2, 2024, 4:15 PM EDT - 1 year ago

Certara Completes Acquisition of Chemaxon

Final Trade: Certara, Nextera Energy, Knight-Swift Transportation and Lululemon

Sep 27, 2024, 6:37 PM EDT - 1 year ago

Final Trade: Certara, Nextera Energy, Knight-Swift Transportation and Lululemon

KNX LULU NEE

Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug

Sep 18, 2024, 8:00 AM EDT - 1 year ago

Certara & Ichnos Glenmark Innovation Collaboration Optimizes Dosing Strategy for Potential First-In-Class Cancer Drug

Certara Launches Phoenix™ Version 8.5 Drug Development Software

Aug 15, 2024, 4:15 PM EDT - 1 year ago

Certara Launches Phoenix™ Version 8.5 Drug Development Software

stockingu
stockingu Jan. 14 at 3:01 PM
$PRSU, $CERT , $CRWV , $CRCL
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 13 at 8:24 PM
$CERT RSI: 51.55, MACD: 0.0287 Vol: 0.30, MA20: 9.05, MA50: 9.17 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
UgoGreg
UgoGreg Jan. 10 at 3:41 PM
$CERT https://youtu.be/ygBN8MilTyc
0 · Reply
ItoLemmaI
ItoLemmaI Dec. 26 at 3:51 PM
$CERT Expectations are recalibrating toward pragmatic delivery instead of lofty projections. Efficiency initiatives must translate into measurable productivity. Overextension would degrade optionality during downturns. The trajectory strengthens as results compound visibly.
0 · Reply
JarvisFlow
JarvisFlow Dec. 18 at 5:42 PM
Morgan Stanley has updated their rating for Certara ( $CERT ) to Equal-Weight with a price target of 12.
0 · Reply
JarvisFlow
JarvisFlow Dec. 15 at 8:57 PM
Barclays has updated their rating for Certara ( $CERT ) to Overweight with a price target of 13.
0 · Reply
Estimize
Estimize Dec. 15 at 12:09 PM
Wall St is expecting 0.11 EPS for $CERT Q4 [Reporting 02/26 AMC] http://www.estimize.com/intro/cert?chart=historical&metric_name=eps&utm_co
0 · Reply
JarvisFlow
JarvisFlow Dec. 12 at 12:43 PM
Stephens & Co. updates rating for Certara ( $CERT ) to Overweight, target set at 15 → 12.
0 · Reply
BigDaddyCapital
BigDaddyCapital Dec. 11 at 8:33 PM
$CDXS I’m not sure which company is a bigger bioturd… $CDXS OR $CERT. Both are awful investments.
1 · Reply
BigDaddyCapital
BigDaddyCapital Dec. 11 at 2:53 PM
$CERT worst company in biotech…
0 · Reply
Estimize
Estimize Dec. 1 at 12:09 PM
Wall St is expecting 0.11 EPS for $CERT Q4 [Reporting 02/26 AMC] http://www.estimize.com/intro/cert?chart=historical&metric_name=eps&utm_co
0 · Reply
BigDaddyCapital
BigDaddyCapital Nov. 19 at 9:42 PM
$CERT biggest shitco on biotech/pharma this year
0 · Reply
BigDaddyCapital
BigDaddyCapital Nov. 18 at 2:44 PM
$CERT worst performer in November… does management not care? I mean wtf
0 · Reply
dragon_heart
dragon_heart Nov. 17 at 7:28 AM
11/17/2025 short $CERT $DNOW $MWA 10MA < 30MA and 30MA < 40MA
0 · Reply
JarvisFlow
JarvisFlow Nov. 13 at 10:26 AM
BMO Capital updates rating for Certara ( $CERT ) to Market Perform, target set at 9.
0 · Reply
CEOBuysDisclosures
CEOBuysDisclosures Nov. 12 at 11:50 PM
$CERT CEO purchased 24,096 shares at $8.30 for a total of $199,997. Feehery William F now owns 2,360,769 shares. https://ceo-buys.com
0 · Reply
BigDaddyCapital
BigDaddyCapital Nov. 11 at 3:46 PM
$CERT at this point they need to just sell the company
0 · Reply
BigDaddyCapital
BigDaddyCapital Nov. 11 at 3:01 PM
$CERT so market pricing bankruptcy
0 · Reply
jguerne
jguerne Nov. 8 at 5:25 AM
$EVH $CERT that’ll be $20 @cheapostock wants his cut too
2 · Reply
SuperGreenToday
SuperGreenToday Nov. 8 at 2:16 AM
$CERT Share Price: $8.67 Contract Selected: May 15, 2026 $10 Calls Buy Zone: $0.59 – $0.73 Target Zone: $1.10 – $1.35 Potential Upside: 75% ROI Time to Expiration: 188 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
BigDaddyCapital
BigDaddyCapital Nov. 8 at 1:14 AM
$CERT I think this is the worse drop the company has ever had since IPO
1 · Reply
AlphaBull_10M
AlphaBull_10M Nov. 7 at 8:22 PM
$AIRS $NTLA $FOXF $CERT $DNA Top % losers for the day. Good thing I have none of these, but I'll pick through and see if there is a strong hidden value in some of these.
0 · Reply